Market Signal Briefing

The recent surge in oil and gas prices has driven up inflation expectations, causing markets to adjust their bets on Federal Reserve rate cuts, with traders now pricing in a near 40% chance of no rate cuts this year. Mar 28, 2026, 4:39 p.m.

Bitcoin BTC$66,871.91 may have already priced in the effects of tighter monetary policy, leaving stocks more exposed to the latest macroeconomic shocks, according to asset manager Bitwise.

The firm’s comments come as the cryptocurrency continues to correct below $70,000, down more than 23.7% year-to-date.

Geopolitical unrest and energy disruptions, particularly from the U.S.-Iran conflict choking the Strait of Hormuz, have driven oil and gas prices higher in recent weeks. That surge has put pressure on inflation expectations, causing markets to walk back earlier bets on Federal Reserve rate cuts.

On prediction markets including Polymarket and Kalshi, the perceived odds of the Fed cutting interest rates this year went from near-certainty to doubtful. Traders are now pricing in a near 40% chance that rates aren’t cut at all, up from less than 3%.

“Energy prices remain closely linked to inflation expectations,” said Luke Deans, senior research associate at Bitwise. “The recent surge has led to a meaningful shift in monetary policy pricing, with previously anticipated Federal Reserve rate cuts for the year largely reversing toward expectations of renewed tightening.”

While equities have started to fall in response, with the S&P 500 index losing nearly 8% over the past month, Bitwise argues that bitcoin has already adjusted. The cryptocurrency has been drifting lower since October 2025, reflecting its sensitivity to liquidity and investor risk appetite.

“Bitcoin, a highly reflexive and liquidity-sensitive asset, typically responds earlier to shifts in risk appetite,” Deans said. This suggests that digital assets began reflecting tighter financial conditions ahead of many traditional risk assets. Relative valuation indicators further reinforce this dynamic.”

One indicator, the Mayer Multiple, which compares bitcoin’s spot price to its 200-day average, has sat in the lower percentiles of its historical range since January, Deans said. That suggests BTC has already endured a broad reset in expectations.

In contrast, he said, equities entered the year “at elevated valuation levels and have only more recently begun to reprice as macro conditions deteriorated.”

“Historically, assets that have undergone substantial valuation compression tend to exhibit reduced downside sensitivity as leverage and speculative positioning are progressively unwound,” Deans told CoinDesk. “Alternatively, markets trading closer to cyclical highs often retain greater vulnerability to negative macro catalysts.”

Within crypto, bitcoin’s dominance has tightened the market structure. Bitwise noted that correlations across altcoins have surged, pointing to a single-factor environment driven by BTC’s price.

More For You

As stablecoins evolve into core financial infrastructure, North America leads. This report maps the regulation, market shifts, and players driving adoption.

Why it matters:

Stablecoins are entering their third phase of evolution - the institutionalization era - becoming increasingly embedded into core financial infrastructure. As institutions prioritize transparency and compliance, regulated issuers like USDC, RLUSD, and PYUSD are steadily gaining share with RLUSD surpassing $1B in market cap within its first year. North America, leading in regulatory frameworks and institutional distribution, is at the center of it all.

More For You

The average public miner spent $79,995 to produce one bitcoin last quarter. Bitcoin is trading at $70,000. The math doesn't work, so the industry is pivoting to AI, taking on $70 billion in contracts, and liquidating bitcoin treasuries to finance the shift.

What to know:

Publicly listed bitcoin miners are facing unsustainable economics, losing roughly $19,000 per coin produced, and are rapidly pivoting toward artificial-intelligence and high-performance computing infrastructure.More than $70 billion in AI and HPC contracts have been signed, and some miners could derive up to 70 percent of their revenue from AI...

Morgan Stanley’s low-fee bitcoin ETF filing challenges Blackrock’s dominance and signals intensifying price competition, with adviser-driven distribution poised to influence flows and reshape the balance of power among spot ETF issuers.

Morgan Stanley Undercuts Blackrock With Low-Fee Bitcoin ETF Filing A shift in bitcoin exchange-traded funds (ETFs) pricing is emerging after Morgan Stanley filed Amendment No. 3 to its S-1 registration on March 27, outlining a proposed low-fee structure for a spot bitcoin product. The filing signals a potential inflection point for cost dynamics and competition among issuers. Bloomberg ETF analyst Eric Balchunas shared on social media platform X:

“Semi-shock: Morgan Stanley’s bitcoin ETF will charge 14bps, making it the cheapest spot bitcoin ETF on the market and 11bps cheaper than IBIT.”

“This means none of their advisors will feel conflicted using it and they have shot at getting outside assets. Smart. Launch prob in next two weeks,” the analyst stated. He believes that the pricing advantage could ease allocation decisions within advisory channels while opening the door to external inflows.

Another Bloomberg ETF analyst, James Seyffart, commented on X: “WOW. We have the fee on Morgan Stanley’s spot bitcoin ETF MSBT. Will charge just 0.14% !!! Big move here. They are not messing around. Likely to launch in early April.”

The amended registration describes a proposed fund structure centered on cost efficiency and direct bitcoin exposure, positioning the product against existing spot ETF offerings with higher expense ratios. The development introduces potential downward pressure on fees across issuers competing for institutional and adviser-driven allocations. According to the prospectus, the Morgan Stanley Bitcoin Trust is designed as a passive vehicle that tracks bitcoin using the Coindesk Bitcoin Benchmark 4PM NY Settlement Rate while holding bitcoin directly without leverage or derivatives. The fund facilitates share creation and redemption through bitcoin transfers tied to large basket sizes, with authorized participants able to transact in cash or in-kind via designated counterparties.

Blackrock Dominance Faces Pressure as Morgan Stanley Scale Looms Comparative data shows Blackrock’s Ishares Bitcoin Trust ETF (IBIT) carries a 0.25% expense ratio and holds approximately 785,241 BTC valued at approximately $54.09 billion, representing a 100% allocation to bitcoin with minimal cash exposure as of March 26. The scale of these holdings underscores its dominant market position, while the fee differential highlights how Morgan Stanley’s proposed pricing could challenge established leaders.

Additional projections point to significantly larger potential inflows tied to Morgan Stanley’s wealth management platform. Phong Le, president and CEO of Strategy, stated that Morgan Stanley Wealth Management oversees about $8 trillion in client assets and recommends a 0%–4% bitcoin allocation range, which could translate into substantial demand. “A 2% allocation would represent $160 billion, ~3x the size of IBIT. MSBT: Monster Bitcoin,” Le said. The estimate highlights how even modest portfolio shifts could materially expand the scale of spot bitcoin ETF markets.

Fee positioning across issuers shows a tight clustering below 0.30%, with Morgan Stanley’s proposed 0.14% undercutting rivals, including Grayscale’s Bitcoin Mini Trust at 0.15%, Franklin Templeton’s EZBC at 0.19%, and offerings from Bitwise and Vaneck at 0.20%. Ark 21Shares maintains a 0.21% fee, while Blackrock’s IBIT, Fidelity’s FBTC, and Invesco Galaxy’s BTCO each sit at 0.25%, underscoring the significance of further compression at the lower end of the range.

Scale remains a defining factor in the proposal’s broader implications. The Bloomberg analyst noted:

“The reason this particular launch is so interesting is that this will be the first bank to put out spot BTC ETF and this bank happens to have 16K advisors managing $6T in assets. They are the ultimate gatekeepers of rich boomer money.”

He pointed to adviser influence as a key driver that could shape flows and competitive responses across the bitcoin ETF market.

FAQ 🧭 Why does Morgan Stanley’s ETF fee matter for investors?
Lower fees can improve returns and influence adviser allocations at scale. How could this impact competing bitcoin ETFs?
It may pressure rivals like Blackrock and Grayscale to reduce fees. What makes Morgan Stanley’s distribution unique?
Its adviser network controls trillions in assets that could drive inflows. Is the ETF backed by actual bitcoin?
Yes, it is structured as a fully backed spot bitcoin vehicle.

Cover image via U.Today Disclaimer: The opinions expressed by our writers are their own and do not represent the views of U.Today. The financial and market information provided on U.Today is intended for informational purposes only. U.Today is not liable for any financial losses incurred while trading cryptocurrencies. Conduct your own research by contacting financial experts before making any investment decisions. We believe that all content is accurate as of the date of publication, but certain offers mentioned may no longer be available.

In a recent tweet, Ripple CTO emeritus David Schwartz debunks recent misconceptions concerning the XRP escrow. An X user had brought to attention a 2025 tweet by the Ripple CTO emeritus.

In this tweet, Schwartz had highlighted an escrow functionality whereby funds can only be sent into circulation until the release dates, when the conditions of the contract are met.

This was taken to mean the availability of pre-allocated XRP contracts; an X user had wrongfully implied that the majority of the XRP escrow was earmarked for someone. This, the Ripple CTO clearly stated, was false.

HOT Stories

This discussion was revisited by the Ripple CTO emeritus, who clarified the intent of the 2025 tweet and what he meant, adding that the tweet was misconstrued as inside information on the XRP escrows.

What I said is an obvious fact apparent to anyone who understands how XRPL and the escrow works. It was spun as inside information confirming a theory.

— David 'JoelKatz' Schwartz (@JoelKatz) March 27, 2026 "What I said is an obvious fact apparent to anyone who understands how XRPL and the escrow works. It was spun as inside information confirming a theory," Schwartz said.

XRP escrow explainedAn escrow represents a contract between two parties to facilitate financial transactions. An impartial third party receives and holds funds, and only releases them to the intended recipient when conditions specified by the contract are met. This method will see to it that both parties meet their obligations.

You Might Also Like

XRP Ledger takes escrow a step further, replacing the third party with an automated system built into the ledger. An escrow locks up XRP or fungible tokens, which cannot be used or destroyed until conditions are met.

The token escrow functionality enabled on Feb. 12 this year extended escrow functionality to fungible tokens, enabling trust line tokens and multi-purpose tokens (MPTs) to be held in escrow. Issuers can control whether their tokens can be escrowed through flags.

Crypto industry at turning pointAccording to Ripple CEO Brad Garlinghouse, the industry is reaching a critical turning point where traditional financial giants are finally ready to embrace blockchain technology.

In a recent interview with Fox Business, Garlinghouse described stablecoins as the "ChatGPT moment" of finance, noting that $33 trillion in stablecoin transactions occurred in the past year.

PNC Financial Services (PNC) is rated a buy, trading 17% off its highs and attractively valued relative to historical P/E and book ratios. PNC delivered strong Q4 and FY 2025 results, with record net interest income, 21% EPS growth, and successful FirstBank integration. Management guides to 11% revenue and 14% net interest income growth for FY 2026, with plans for $700M in share repurchases and efficiency gains via AI.

Walmart (WMT +0.71%) and Costco (COST +0.45%) have started 2026 by building on their strong results of the last few years. Costco shares are up more than 9%, and Walmart is up more than 12% year to date, while the S&P 500 is down for the year.

Both companies have benefited from strong financial results driven by their e-commerce operations and by a macroeconomic environment that has driven consumers to seek value.

While Walmart and Costco might offer great values for their shoppers, investors might not see as much value in their stocks. The market may have gotten ahead of the retailers' financial performance over the past few years, bidding up their stock prices and increasing their valuations.

But investors looking for value in the retail segment may have an opportunity from an unexpected candidate. Its stock currently trades at a much lower valuation than either Walmart or Costco.

Image source: Getty Images.

The market is putting this retail giant on sale As mentioned, both Walmart and Costco are seeing very positive results from their e-commerce operations. Walmart saw U.S. e-commerce sales climb 27% last quarter, marking its eighth straight quarter of growth above 20%. Costco's e-commerce sales climbed 22.6% last quarter. Walmart has also expanded its advertising business, adding more retail media and video content through its Vizio acquisition. Walmart's U.S. digital advertising sales climbed 41% last quarter.

Today's Change

(

0.71

%) $

0.87

Current Price

$

123.05

Despite their progress in e-commerce, though, both Walmart and Costco are failing to take market share from Amazon (AMZN 3.89%), which continues to hold a dominant position. Amazon's e-commerce market share expanded from 34.4% in 2024 to 35.7% in 2025, according to research from Marketplace Pulse. While online store sales, third-party seller services, and subscription services all grew more slowly on a percentage basis than Walmart and Costco's e-commerce operations, Amazon is working off such a massive base that even its relatively modest growth has a huge impact on the market.

Importantly, Amazon's retail operations are primarily digital, whereas Walmart and Costco still derive the majority of their revenue from their physical stores. As such, Walmart and Costco's overall revenue growth of 5.6% and 7.4%, respectively, in their most recently reported quarters, is still below the 10% growth Amazon exhibited in the fourth quarter. And while both are seeing operating margin improvements, so too is Amazon.

As such, it's somewhat curious that Amazon trades for an enterprise value that's just 10.8 times analysts' expectations for its 2026 earnings before interest, taxes, depreciation, and amortization (EBITDA). Meanwhile, investors give Walmart a multiple above 21 and Costco a multiple of nearly 30.

Amazon's retail business continues to grow its top and bottom lines faster than Walmart's or Costco's. In fact, analysts expect Amazon's EBITDA to climb 40% this year and another 23% in 2027. Growth expectations for Walmart and Costco are just 10% and 8% per year, respectively, over the next two years.

The big cloud hanging over Amazon There's a clear explanation for investors' reluctance to bid up the price of Amazon: its massive cloud computing business, Amazon Web Services (AWS). Indeed, AWS accounted for the majority of Amazon's operating income in 2025, generating $45.6 billion of Amazon's $80 billion in total income from operations. As such, investor sentiment about the cloud business is going to have an outsize impact on the company's overall valuation.

Management surprised analysts in January when it announced plans to spend more than $200 billion in capital expenditures this year, mostly to build out compute capacity for AWS. Management continued to reiterate several positive signals for its cloud computing business, including the fact that it remains supply-constrained.

Accelerating its investments in AWS can help it capitalize on market opportunities right now. "We have deep experience understanding demand signals in the AWS business and then turning that capacity into a strong return on invested capital. We are confident this will be the case here as well," CEO Andy Jassy explained on Amazon's fourth-quarter earnings call.

Today's Change

(

-3.89

%) $

-8.07

Current Price

$

199.47

The step up in spending will likely push Amazon's free cash flow into negative territory in 2026. For a company that's often held up free cash flow as the most important metric over the long run, that increases the uncertainty about the business, which also depresses the earnings multiple investors are willing to pay. It also means depreciation will increase, a real expense that investors won't find in EBITDA, which should, in turn, result in a lower EBITDA multiple.

Perhaps looking at earnings per share is a better judge of value. There, the gap isn't quite as pronounced, but Amazon still trades at a significant discount. Investors are currently paying just 27 times analysts' earnings estimates for Amazon, where Walmart and Costco trade for 42 and 48 times forward earnings, respectively.

As such, investors appear to be significantly undervaluing Amazon due to low expectations for its return on invested capital for its cloud computing business. Long-term investors are either getting a deal on the cloud computing business or the retail business relative to Walmart and Costco. Either way, it looks like a fantastic buying opportunity.

Did you buy SMR Class A common stock between May 13, 2025, and November 6, 2025?

Affected NuScale Power Corporation Investor Summary

Who: NuScale Power Corporation (NYSE: SMR) What: Securities fraud class action lawsuit filed Class Period: May 13, 2025, through November 6, 2025 Deadline to Seek Lead Plaintiff Status: April 20, 2026 Key Lawsuit Allegations: Material misstatements and/or omissions concerning the company's commercialization strategy for its nuclear power generation projects and development. Investor Action: Contact Kessler Topaz Meltzer & Check, LLP (www.ktmc.com) for recovery options at no cost to investor , /PRNewswire/ -- Kessler Topaz Meltzer & Check, LLP (www.ktmc.com), a nationally recognized securities litigation law firm, informs investors that a securities fraud class action lawsuit has been filed against NuScale Power Corporation (NuScale) (NYSE: SMR) on behalf of those who purchased or acquired NuScale Class A common stock between May 13, 2025, and November 6, 2025, inclusive. The lawsuit is filed in the United States District Court for the District of Oregon and is captioned Truedson v. NuScale Power Corporation, et al, Case No. 3:26-cv-00328 (D. Or.).  Investors have until April 20, 2026, to file for lead plaintiff status. 

CONTACT KTMC TO DISCUSS YOUR LEGAL RIGHTS:    
If you purchased or acquired NuScale Class A common stock and have lost money on your investment, you are encouraged to contact KTMC attorney Jonathan Naji, Esq. at:

(484) 270-1453
[email protected]
https://www.ktmc.com/smr-nuscale-power-corporation-class-action-lawsuit?utm_source=PR_Newswire&utm_medium=pressrelease&utm_campaign=smr&mktm=PR

There is no cost or obligation to speak with an attorney.

Learn more about NuScale Power Corporation on YouTube:

 NuScale Power Corporation  Securities Class Action Lawsuit (long video)  NuScale Power Corporation Securities Class Action Lawsuit (short video) NUSCALE POWER CORPORATION CLASS ACTION LAWSUIT - COMPLAINT ALLEGATION SUMMARY:
The complaint alleges that, throughout the Class Period, Defendants made false and/or misleading statements and/or failed to disclose that: (1) ENTRA1 Energy LLC ("ENTRA1") had never built, financed, or operated any significant projects– let alone projects in the highly technical and complicated field of nuclear power generation during its entire operating history; (2) NuScale had entrusted its commercialization, distribution, and deployment of its NuScale Power Module and hundreds of millions of dollars of NuScale capital to an entity that lacked any significant prior experience owning, financing, or operating nuclear energy generation facilities; (3) the purported experience and qualifications attributed to ENTRA1 by Defendants during the Class Period in fact referred to the purported experience and qualifications of the principals of the Habboush Group, a distinct entity without significant experience in the field of nuclear power generation; and (4) as a result, NuScale's commercialization strategy was exposed to material, undisclosed risks of failure, delays, regulatory challenges, or other negative setbacks.

Why did NuScale's Stock Drop?
On November 6, 2025, NuScale surprised investors by revealing that the company's general and administrative expenses had ballooned more than 3,000% to $519 million during its third fiscal quarter, up from $17 million in the prior year period, due largely to NuScale's payment of $495 million to ENTRA1 for its TVA agreement. As a result, NuScale's quarterly net loss skyrocketed to $532 million, up from $46 million in the prior year period. On this news, the price of NuScale Class A common stock declined by $5.45 per share, or approximately 14.4%, from a close of $37.91 per share on November 5, 2025, to close at $32.46 on November 6, 2025.

WHAT SMR INVESTORS CAN DO NOW:

File to be lead plaintiff by April 20, 2026. Contact KTMC for a free case evaluation. All representation is on a contingency fee basis, there is no cost to you. Retain counsel of choice or take no action. THE LEAD PLAINTIFF PROCESS FOR NUSCALE POWER CORPORATION INVESTORS:
NuScale investors may, no later than April 20, 2026, seek to be appointed as a lead plaintiff representative of the class through Kessler Topaz Meltzer & Check, LLP or other counsel, or may choose to do nothing and remain an absent class member. A lead plaintiff is a representative party who acts on behalf of all class members in directing the litigation.  The lead plaintiff is usually the investor or small group of investors who have the largest financial interest and who are also adequate and typical of the proposed class of investors. The lead plaintiff selects counsel to represent the lead plaintiff and the class and these attorneys, if approved by the court, are lead or class counsel. Your ability to share in any recovery is not affected by the decision of whether or not to serve as a lead plaintiff.

Kessler Topaz Meltzer & Check, LLP encourages NuScale investors to contact the firm for more information.

ABOUT KESSLER TOPAZ MELTZER & CHECK, LLP (KTMC):    
Kessler Topaz Meltzer & Check, LLP (KTMC) is a leading U.S. plaintiff-side law firm focused on securities-fraud class actions and global investor protection. The firm represents individual investors as well as institutions, such as major pension funds, asset managers, and international investors. KTMC has led some of the largest recoveries in securities litigation and has been recognized by peers and the legal media with numerous accolades, including The National Law Journal's Plaintiff's Hot List and Trailblazers in Plaintiffs' Law, BTI Consulting Group's Honor Roll of Most Feared Law Firms, The Legal Intelligencer's Class Action Firm of the Year, Lawdragon's Leading Plaintiff Financial Lawyers, and Law360's Titans of the Plaintiffs Bar.  The firm operates globally with offices in Pennsylvania and California.  KTMC has recovered over $25 billion for our clients and the classes they represent.  For more information about Kessler Topaz Meltzer & Check, LLP, please visit www.ktmc.com.  The complaint in this matter was not filed by KTMC.

CONTACT:
Jonathan Naji, Esq.
(484) 270-1453
280 King of Prussia Road
Radnor, PA 19087
[email protected]

May be considered attorney advertising in certain jurisdictions.  Past results do not guarantee future outcomes.

SOURCE Kessler Topaz Meltzer & Check, LLP

HomeETFs and Funds AnalysisETF Analysis

SummaryFirst Trust NASDAQ Technology Dividend Index Fund (TDIV) remains a compelling buy after a recent 5% pullback amid broader tech sector volatility.TDIV’s valuation premium to the S&P 500 has sharply narrowed, making entry points more attractive for long-term investors.The tech sector’s forward outlook into 2026 is robust, supporting continued allocation despite near-term market turbulence.TDIV’s year-over-year dividend growth of 16% in Q2 2025 underscores the fund’s income reliability and growth potential.This idea was discussed in more depth with members of my private investing community, CEF/ETF Income Laboratory. Learn More » Klaus Vedfelt/DigitalVision via Getty Images

Main Thesis & Background The purpose of this article is to evaluate the First Trust NASDAQ Technology Dividend Index Fund (TDIV) as an investment option at its current market price. The fund "seeks investment results

9.61K Followers

Analyst’s Disclosure: I/we have a beneficial long position in the shares of TDIV, QQQM, VOO either through stock ownership, options, or other derivatives. I wrote this article myself, and it expresses my own opinions. I am not receiving compensation for it (other than from Seeking Alpha). I have no business relationship with any company whose stock is mentioned in this article.

Seeking Alpha's Disclosure: Past performance is no guarantee of future results. No recommendation or advice is being given as to whether any investment is suitable for a particular investor. Any views or opinions expressed above may not reflect those of Seeking Alpha as a whole. Seeking Alpha is not a licensed securities dealer, broker or US investment adviser or investment bank. Our analysts are third party authors that include both professional investors and individual investors who may not be licensed or certified by any institute or regulatory body.

Texas Capital Bancshares delivered strong 2025 results, with net income of $330 million and EPS of $6.86, supporting robust capital levels. Net interest income rose 14% to $1.03 billion, aided by a 10% drop in interest expenses and reduced loan loss provisions, enhancing earnings quality. TCBI completed a $200 million share buyback and launched another, while tangible book value climbed to $75 per share, keeping valuation attractive at

When it comes to video entertainment, Netflix needs no introduction. It counts 325 million subscribers in more than 190 countries. And it generated $45 billion in revenue in 2025.

This streaming stock has skyrocketed 838% in the past 10 years (as of March 25), a performance that certainly gets a lot of attention. Investors focused on Netflix need to look at another dominant company, however. It's a notable winner in the streaming wars.

But Netflix also has some serious competition out there from a well-known tech giant.

Image source: Alphabet.

It's hard to overlook this technology powerhouse You might not immediately think of Alphabet (GOOGL 2.30%) (GOOG 2.45%) as a competitor to Netflix. It is a massive technology enterprise with its hands in numerous industries. But it also owns YouTube, which is undeniably a leading video streaming platform that is giving Netflix a run for its money.

In 2025, YouTube alone raked in $60 billion in revenue, which is 33% more than Netflix registered. Of that $60 billion, $40 billion came from advertising. Subscriptions, like YouTube TV, YouTube Music and Premium, and NFL Sunday Ticket, accounted for the remainder.

It's not exactly a surprise to learn that YouTube makes so much money from ads, as this is Alphabet's bread and butter. But what is worth pointing out is that Netflix's growth driver, which is its booming ad segment that's projected to double sales in 2026, puts it more in direct competition with YouTube.

Today's Change

(

-2.30

%) $

-6.45

Current Price

$

274.47

Turn on the TV Investors should pay close attention to engagement data. According to Nielsen, 12.5% of all TV viewing time in the U.S. in the month of January went to YouTube. That's 42% higher than the 8.8% share that Netflix represented. Alphabet Chief Business Officer Philipp Schindler points out that YouTube "remains the No. 1 streamer in the U.S. for nearly three years."

When measuring TV viewing time, Nielsen counts only YouTube's main platform. It excludes the live linear streaming component. This makes it a fair comparison.

But the business models aren't exactly the same. Netflix spends tons of money, $20 billion planned in 2026, to license and produce its own content. YouTube, on the other hand, specializes in user-generated content. That's a big difference. Nonetheless, viewers are more interested in what YouTube offers. And this will make it more difficult for Netflix to capture more attention.

YouTube also benefits from a network effect, which supports its staying power. If creators produce more content that caters to wider audiences, it attracts more viewers. Consequently, as engagement and viewership increase, it further incentivizes more content to be created. This means that YouTube is constantly getting better over time.

This is all wonderful news for Alphabet shareholders. Netflix investors, however, must keep a close eye on these trends.

Midnight Sun Mining Corp (TSX-V:MMA, OTCQB:MDNGF) Vice President Adrian O'Brien talked with Proactive about the company’s latest progress at its Dumbwa Project in Zambia, where drilling continues to define a potentially large-scale copper discovery.

Proactive: Let’s remind everyone about the project and the work to date.

Adrian O'Brien: We’re in the most exciting phase now—the resource delineation phase. We made a discovery at Dumbwa in August and have drilled 166 holes so far. We’ve stayed on the system the entire time, though only 29 holes have assays released so far. This thing is really taking shape. We’ve already established four kilometres of strike length. The broader target is a 20km copper-in-soil anomaly—almost unprecedented in Zambia.

Are you focusing on one area or multiple targets?

The drilling is along one main target in the southeast of our property in Zambia’s domes region, known for large, near-surface deposits. It’s analogous to Barrick’s Lumwana mine. Our COO Kevin Bonel, who advanced Lumwana, is leading this work.

What’s the drilling plan for this year?

We’re drilling it like a major would—tight spacing at 50 metres, with 100–200 metre line spacing across the 20km target. We’re drilling about 10,000 metres per month with five rigs and have a $20 million budget, backed by $35 million in cash. Our goal is to define the first 12km by Q3, targeting 1 to 1.5 billion tonnes.

Are you working toward reports?

Yes, that will position us for an initial MRE on the first half of the deposit. We’ll then decide whether to continue north or explore additional targets.

There’s also a geopolitical angle here. Can you explain?

There’s a perfect storm for M&A in Zambia. Major companies are all looking for large copper deposits. At the same time, infrastructure developments like the Lobito Corridor and competing rail lines backed by the US and China highlight the global demand for copper. Midnight Sun is positioned right in the middle of this dynamic.

Quotes have been lightly edited for style and clarity

23.37K Followers

Analyst’s Disclosure: I/we have no stock, option or similar derivative position in any of the companies mentioned, and no plans to initiate any such positions within the next 72 hours. I wrote this article myself, and it expresses my own opinions. I am not receiving compensation for it (other than from Seeking Alpha). I have no business relationship with any company whose stock is mentioned in this article.

Seeking Alpha's Disclosure: Past performance is no guarantee of future results. No recommendation or advice is being given as to whether any investment is suitable for a particular investor. Any views or opinions expressed above may not reflect those of Seeking Alpha as a whole. Seeking Alpha is not a licensed securities dealer, broker or US investment adviser or investment bank. Our analysts are third party authors that include both professional investors and individual investors who may not be licensed or certified by any institute or regulatory body.

Fusion company TAE Technologies was facing a funding crunch last year when it found an unlikely partner.

Progressive's (PGR 2.26%) earnings per share have ramped from a trough of about $1 in 2022 to close to $20 in 2025. Big swings come with the territory in property and casualty insurance, where hard markets let insurers raise premiums and soft markets are more competitive, eventually bringing margins back down.

With shares down around 25% over the past year, the magnitude of this swing has come into focus. Prior to this cycle, the company's EPS had never crossed the $10 mark. The durability of Progressive's recent earnings run now depends on how much was driven by its underwriting skill versus a favorable turn in the cycle.

Image source: Getty Images.

The data engine behind the wheel The company remains one of the industry's best underwriters, using decades of claims history and telematics data to price risk with more precision than most. Its long-term goal is to maintain a combined ratio below 96%.

For this measure of insurer profitability, the further the company lands below 100%, the greater the profit. Progressive was far better than that in 2025, with a combined ratio of 87.4%, showing how strong this cycle has been. But its clearest advantage in this cycle was growth.

While the entire industry became more profitable as rates rose over the past few years, Progressive grew the fastest. Its net premiums written jumped roughly 16% annually from 2021 to 2025.

That combination of disciplined underwriting and share gains is the engine that drove earnings from a trough of about $1 per share in 2022 to over $19 in 2025. That same discipline works in reverse, because if the market softens and pricing gets more competitive, the company is unlikely to chase growth at the expense of profit margins.

The cycle always turns The tailwinds that propelled earnings growth are now changing. Progressive picked up roughly two points of personal auto market share in 2025, but the broader cycle was also highly favorable for insurers. That makes it harder to tell how much of the recent earnings surge came from company-specific execution and how much came from unusually strong industry conditions.

Some of those gains may prove durable, but not all of them are guaranteed to stick. If the market keeps getting more competitive, Progressive's discipline could mean giving some of that share back rather than writing weaker business. The easiest stretch of cycle-driven growth is likely behind it.

Today's Change

(

-2.26

%) $

-4.59

Current Price

$

198.31

Progressive remains a high-quality insurer with an underwriting edge that should hold up through the cycle. At 12.5 times forward earnings, the stock no longer carries the premium it did a year ago. But that multiple sits on top of earnings that may prove unusually high. If price competition firms up, pushing margins back toward more normal levels, the earnings base under that multiple will shrink.

HomeIndustriesSoftwareTech StocksTech StocksCEO Nikesh Arora put his own money on the line to buy up the beleaguered cybersecurity stock as it got weighed down by concerns about a new Anthropic AI modelPublished: March 28, 2026 at 12:17 p.m. ET

Palo Alto Networks CEO Nikesh Arora sought to buy the dip as cybersecurity stocks sold off Friday in the face of fresh artificial-intelligence concerns.

Arora purchased about $10 million worth of Palo Alto Networks shares PANW Friday at prices between $146.46 and $147.48, according to a filing with the Securities and Exchange Commission.

Abacus Global Management (NYSE:ABX) earlier this week reported record-setting financial and operational performance for 2025, highlighting strong momentum in the rapidly expanding life settlements market.

CEO Jay Jackson said the company delivered more than 100% year-over-year growth across key financial metrics, including EBITDA, adjusted net income, and gross results. He emphasized that beyond headline figures, the underlying operational activity demonstrated the strength of the platform.

Jackson noted that Abacus acquired more than 1,300 life insurance policies during the year and generated nearly $180 million in realized gains. The company also sold over 1,000 policies, underscoring the liquidity and scalability of its model. He added that more than $600 million in capital was deployed, enabling over 1,100 seniors to access value from previously illiquid assets.

“We're helping clients find liquidity in assets they didn’t know had it — their life insurance policies,” Jackson said.

Jackson explained that life insurance policies are increasingly being recognized as a viable financial asset class.

Looking ahead, Jackson pointed to a substantial growth runway, noting that the total addressable market is approximately $14 trillion, while Abacus has only penetrated a small fraction of that opportunity. He suggested that ongoing macroeconomic uncertainty is driving investor demand for uncorrelated assets, positioning life settlements as an attractive alternative.

As a key catalyst for future growth, the company recently completed a minority investment in Manning & Napier, a long-established wealth and asset management firm. Jackson said the partnership provides access to more than 3,400 retail clients, many of whom may not yet be aware of the liquidity potential within their life insurance holdings.

He indicated that this strategic relationship could enhance origination volumes and contribute to continued record performance into 2026.

“We’re one of the largest originators, and our record numbers are an indicator of what’s coming next,” he said.

Rezpegaldesleukin demonstrates statistically significant improvement in mean percent EASI improvement across both moderate and severe atopic dermatitis patients

Rezpegaldesleukin proof-of-concept data in alopecia areata patients presented as a late-breaking research oral presentation

, /PRNewswire/ -- Nektar Therapeutics (Nasdaq: NKTR) today showcased data in two presentations at the 2026 American Academy of Dermatology (AAD) Annual Meeting taking place in Denver, CO.

At AAD 2026, data from the global Phase 2b REZOLVE-AD study in 393 patients with moderate-to-severe atopic dermatitis were presented by Dr. Raj Chovatiya, Associate Professor at Rosalind Franklin University of Medicine and Science Chicago Medical School and Founder and Director of the Center for Medical Dermatology and Immunology Research, in an oral poster session entitled "Novel Regulatory T-cell enhancing Biologic Rezpegaldesleukin: Phase 2b Efficacy, Safety, and Baseline Severity–Dependent Treatment Response in Moderate-to-Severe Atopic Dermatitis" [link to presentation].

Patient randomization was stratified based on baseline disease severity measured by vIGA-AD® (validated Investigator's Global Assessment for Atopic Dermatitis) and geographic region. As presented at AAD, patients in the Phase 2b REZOLVE-AD study demonstrated consistent reduction in mean Eczema Area and Severity Index (EASI) scores over the 16-week induction period as compared to placebo regardless of baseline disease severity as measured by baseline vIGA-AD® scores of 3 or 4. During the 16-week induction period, patients also achieved comparable EASI-75 (at least a 75% improvement in EASI score from baseline) and EASI-90 response (at least a 90% improvement in EASI score from baseline). These disease improvement metrics were also comparable by geographic region.

"The consistency of EASI responses with rezpegaldesleukin across baseline disease severity further differentiates it from the standard of care biologic treatment, which can have lower response rates in more severe patients as compared to moderate patients," said Raj Chovatiya, MD, PhD, MSCI, FAAD. "We believe its novel agonist mechanism to expand regulatory T cells, which act as master regulators upstream of the cytokine-specific blockade mechanisms of other biologics to address multiple pathways, allows a potentially more consistent improvement across a broader patient population."

Based upon results from the Phase 2b REZOLVE-AD study of rezpegaldesleukin, Nektar is planning to initiate the Phase 3 ZENITH-AD program of rezpegaldesleukin in moderate-to-severe atopic dermatitis patients in the second quarter of 2026.

At AAD 2026, Dr. David Rosmarin presented a late-breaking research oral presentation highlighting previously-released data1 titled: "Novel Regulatory T-cell Enhancing Biologic Rezpegaldesleukin: Phase 2b Efficacy and Safety Results Following 36-Weeks of Therapy in Severe-to-Very-Severe Alopecia Areata" [link to presentation].

On the primary endpoint of mean Severity of Alopecia Tool (SALT) reduction at 36 weeks of treatment, high dose rezpegaldesleukin, 24 µg/kg every two weeks (q2w), demonstrated a mean reduction in the SALT score of 28.2% in the 24 µg/kg arm versus 11.2% in the placebo arm. Mean percent reduction in SALT scores at 36 weeks was 30% for both treatment arms versus 6% in the placebo arm, achieving statistical significance (p<0.05) when excluding four patients that did not meet major study eligibility criteria at baseline. Rezpegaldesleukin was well tolerated and its safety profile was consistent with previously reported results. 

"The clear activity of rezpegaldesleukin in alopecia areata builds on prior results in atopic dermatitis and reinforces the broader potential of this approach across T cell-driven inflammatory diseases," said David Rosmarin M.D., Chair, Department of Dermatology and Associate Professor of Dermatology, Indiana University School of Medicine. "I look forward to the upcoming results from the 16-week treatment extension to evaluate the potential for a deepening of SALT response over time."

About REZOLVE-AD Phase 2b Study

The global REZOLVE-AD (NCT06136741) Phase 2b study enrolled 393 patients with moderate to severe atopic dermatitis who have not previously been treated with a JAK inhibitor or other biologic. Patients were randomized (3:3:3:2) to receive subcutaneous treatment with three doses of rezpegaldesleukin: a high dose of 24 µg/kg every two weeks (Q2W), a middle dose of 18 µg/kg every two weeks (Q2W), and a low dose of 24 µg/kg every four weeks (Q4W), or placebo Q2W. The primary endpoint and secondary endpoints were assessed at the end of the 16-week induction period. Following the induction period, rezpegaldesleukin-treated patients who achieved EASI percent reductions of at least 50 were re-randomized (1:1) to continue at the same dose level on a Q4W or a Q12W regimen through Week 52 in a blinded maintenance period. Placebo patients with EASI percent score reductions of at least 50 continue to receive placebo Q4W.

About REZOLVE-AA Phase 2b Study

The global REZOLVE-AA (NCT06340360) Phase 2b study enrolled 92 patients with severe-to-very-severe alopecia areata who have not previously been treated with a JAK inhibitor or other biologic. Patients were randomized (3:3:2) to receive one of two rezpegaldesleukin doses or placebo, administered as a subcutaneous injection twice-monthly. The primary endpoint was the mean percentage reduction from baseline in the SALT score at 36 weeks. Following 36 weeks of treatment, patients who demonstrated hair growth but had not yet reached SALT>20 had the option to continue for an additional 16 weeks of treatment through 52 weeks in a blinded extension period. Primary and secondary endpoints were assessed at the end of the 36-week induction treatment period.

About Rezpegaldesleukin

Autoimmune and inflammatory diseases cause the immune system to mistakenly attack and damage healthy cells in a person's body. A failure of the body's self-tolerance mechanisms enables the formation of the pathogenic T lymphocytes that conduct this attack. Rezpegaldesleukin is a potential first-in-class resolution therapeutic that may address this underlying immune system imbalance in people with many autoimmune and inflammatory conditions. It targets the interleukin-2 receptor complex in the body to stimulate proliferation of immune-modulating cells known as regulatory T cells. By activating these cells, rezpegaldesleukin may act to bring the immune system back into balance.

In February 2025, the U.S. Food and Drug Administration (FDA) granted Fast Track designation for rezpegaldesleukin for the treatment of adult and pediatric patients 12 years of age and older with moderate-to-severe atopic dermatitis whose disease is not adequately controlled with topical prescription therapies or when those therapies are not advisable. In July 2025, the FDA granted Fast Track designation for rezpegaldesleukin for the treatment of severe alopecia areata (AA) in adults and pediatric patients 12 years of age and older who weigh at least 40 kg.

Rezpegaldesleukin is being developed as a self-administered injection for a number of autoimmune and inflammatory diseases. It is wholly owned by Nektar Therapeutics.

About Nektar Therapeutics

Nektar Therapeutics is a clinical-stage biotechnology company focused on developing treatments that address the underlying immunological dysfunction in autoimmune and chronic inflammatory diseases. Nektar's lead product candidate, rezpegaldesleukin (REZPEG, or NKTR-358), is a novel, first-in-class regulatory T cell stimulator being evaluated in one Phase 2b clinical trial in atopic dermatitis, one Phase 2b clinical trial in alopecia areata, and one Phase 2 clinical trial in Type 1 diabetes mellitus. Nektar's pipeline also includes a preclinical bivalent tumor necrosis factor receptor type II (TNFR2) antibody and bispecific programs, NKTR-0165 and NKTR-0166, and a modified hematopoietic colony stimulating factor (CSF) protein, NKTR-422.

Nektar is headquartered in San Francisco, California. For further information, visit www.nektar.com and follow us on LinkedIn.

Cautionary Note Regarding Forward-Looking Statements

This press release contains forward-looking statements which can be identified by words such as: "pan," "develop," "potential," "expand," "address," "may" and similar references to future periods. Examples of forward-looking statements include, among others, statements regarding the therapeutic potential of, and future development plans for, rezpegaldesleukin, NKTR-0165, NKTR-0166, and NKTR-422. Forward-looking statements are neither historical facts nor assurances of future performance. Instead, they are based only on our current beliefs, expectations and assumptions regarding the future of our business, future plans and strategies, anticipated events and trends, the economy and other future conditions. Because forward-looking statements relate to the future, they are subject to inherent uncertainties, risks and changes in circumstances that are difficult to predict and many of which are outside of our control. Our actual results may differ materially from those indicated in the forward-looking statements. Therefore, you should not rely on any of these forward-looking statements. Important factors that could cause our actual results to differ materially from those indicated in the forward-looking statements include, among others: (i) our statements regarding the therapeutic potential of rezpegaldesleukin, NKTR-0165, NKTR-0166 and NKTR-422 are based on preclinical and clinical findings and observations and are subject to change as research and development continue; (ii) rezpegaldesleukin, NKTR-0165, NKTR-0166 and NKTR-422 are investigational agents and continued research and development for these drug candidates is subject to substantial risks, including negative safety and efficacy findings in future clinical studies (notwithstanding positive findings in earlier preclinical and clinical studies); (iii) rezpegaldesleukin, NKTR-0165, NKTR-0166 and NKTR-422 are in clinical development and the risk of failure is high and can unexpectedly occur at any stage prior to regulatory approval; (iv) data reported from ongoing clinical trials are necessarily interim data only and the final results will change based on continuing observations; (v) the timing of the commencement or end of clinical trials and the availability of clinical data may be delayed or unsuccessful due to regulatory delays, slower than anticipated patient enrollment, manufacturing challenges, changing standards of care, evolving regulatory requirements, clinical trial design, clinical outcomes, competitive factors, or delay or failure in ultimately obtaining regulatory approval in one or more important markets; (vi) a Fast Track designation does not increase the likelihood that rezpegaldesleukin will receive marketing approval in the United States; (vii) patents may not issue from our patent applications for our drug candidates, patents that have issued may not be enforceable, or additional intellectual property licenses from third parties may be required; and (viii) certain other important risks and uncertainties set forth in our Annual Report on Form 10-K filed with the Securities and Exchange Commission on March 13, 2026. Any forward-looking statement made by us in this press release is based only on information currently available to us and speaks only as of the date on which it is made. We undertake no obligation to update any forward-looking statement, whether written or oral, that may be made from time to time, whether as a result of new information, future developments or otherwise.

For Investors:

Vivian Wu
628-895-0661
[email protected]

Corey Davis, Ph.D.
LifeSci Advisors
212-915-2577
[email protected] 

For Media:

Susan Roberts
LifeSci Communications
202-779-0929
[email protected]

Nektar Therapeutics, "REZOLVE-AA Phase 2b Study of Rezpegaldesleukin Establishes Proof-of-Concept in Patients with Severe-to-Very-Severe Alopecia Areata", press release, 12/16/2025, https://ir.nektar.com/news-releases/news-release-details/rezolve-aa-phase-2b-study-rezpegaldesleukin-establishes-proof SOURCE Nektar Therapeutics

Rongchai Wang Mar 28, 2026 14:59

NEAR Protocol trades at $1.18 after testing key support. Technical analysis suggests potential bounce to $1.25-$1.31 range if bulls defend current levels through March 2026.

NEAR Price Prediction Summary • Short-term target (1 week): $1.25 (7% upside from current levels) • Medium-term forecast (1 month): $1.16-$1.31 range with bias toward lower end • Bullish breakout level: $1.46 (Bollinger Band upper resistance) • Critical support: $1.15-$1.16 zone

What Crypto Analysts Are Saying About NEAR Protocol While specific analyst predictions are limited for the current timeframe, historical forecasts provide context for NEAR's potential trajectory. According to previous analysis from January 2026, Jessie A Ellis projected a potential 38-55% upside to the $2.10-$2.35 range by end of January, though this target was not achieved as NEAR currently trades significantly below those levels at $1.18.

On-chain data and technical metrics suggest NEAR Protocol faces a critical juncture at current price levels, with momentum indicators pointing to potential consolidation rather than explosive growth in the near term.

NEAR Technical Analysis Breakdown NEAR Protocol's current technical setup presents a mixed picture with several key indicators worth monitoring for this NEAR price prediction:

RSI Analysis: At 40.69, NEAR's RSI sits in neutral territory, suggesting the token is neither oversold nor overbought. This provides room for movement in either direction, though the reading leans slightly toward bearish sentiment.

MACD Signals: The MACD histogram at 0.0000 indicates bearish momentum, with both MACD (-0.0043) and signal line (-0.0043) in negative territory. This suggests selling pressure may continue in the short term.

Bollinger Band Position: NEAR's position at 0.0654 places it near the lower Bollinger Band at $1.16, indicating potential oversold conditions. The middle band at $1.31 represents the 20-day SMA and serves as a key resistance level.

Moving Average Structure: NEAR trades below most key moving averages, with the 7-day SMA at $1.25 and 20-day SMA at $1.31 both acting as resistance. However, the price sits just below the 50-day SMA at $1.19, suggesting potential for a bounce if bulls step in.

NEAR Protocol Price Targets: Bull vs Bear Case Bullish Scenario In the optimistic case for this NEAR Protocol forecast, a successful defense of the $1.16 support level could trigger a relief rally toward the 7-day SMA at $1.25, representing approximately 6% upside. A break above this level with volume could extend gains to the 20-day SMA at $1.31, marking a 11% increase from current levels.

The ultimate bullish target remains the upper Bollinger Band at $1.46, though reaching this level would require significant buying pressure and a shift in market sentiment. Key confirmation signals would include RSI breaking above 50 and MACD histogram turning positive.

Bearish Scenario The bearish case centers on a breakdown below the critical $1.15-$1.16 support zone. Such a move could trigger additional selling toward the strong support level at $1.15, with further downside risk if this level fails to hold.

Given NEAR's position well below the 200-day SMA at $1.84, the longer-term trend remains decidedly bearish. A failure to reclaim key moving averages could lead to extended consolidation in lower ranges.

Should You Buy NEAR? Entry Strategy Based on current technical levels, potential entry points for NEAR Protocol include:

Conservative Entry: Wait for a successful bounce and hold above $1.19 (immediate resistance) before considering positions, with initial targets at $1.25.

Aggressive Entry: Current levels around $1.18 offer a risk-reward setup for traders comfortable with volatility, using $1.15 as a stop-loss level.

Risk Management: Given the bearish MACD and position below key moving averages, position sizes should be conservative with strict stop-losses below $1.15. The daily ATR of $0.07 suggests typical daily moves of around 6%, which should factor into position sizing decisions.

Conclusion This NEAR price prediction suggests the token faces a critical test at current support levels around $1.16. While technical indicators show mixed signals, the proximity to Bollinger Band support and neutral RSI provide some optimism for a near-term bounce toward $1.25-$1.31.

However, the broader technical picture remains challenging, with NEAR trading well below key moving averages and showing bearish momentum signals. Traders should approach with caution and maintain strict risk management protocols.

Disclaimer: Cryptocurrency price predictions are highly speculative and subject to extreme volatility. This analysis is for informational purposes only and should not be considered financial advice. Always conduct your own research and never invest more than you can afford to lose.

Image source: Shutterstock

near price analysis near price prediction

XRP is showing signs of short-term consolidation, but the broader trend remains under pressure. The price continues to hover above key support zones, giving buyers a slight foothold, but resistance levels and descending trendlines are still limiting upside momentum.

Ripple Price Analysis: The USDT Pair On the XRP/USDT chart, the asset is trading around $1.34. The price is just above the $1.20 support zone that has held recent lows. While there is a mild recovery attempt, XRP remains confined inside the descending channel and below both the 100-day and 200-day moving averages, located around the $1.80 and $2.10 levels, respectively. This still keeps the overall structure bearish.

For the buyers to get back in control, the asset would need to move above the $1.75 to $1.80 area to shift the short-term sentiment more favorably. On the other hand, the $1.20 support zone remains critical, as if a drop below this level could cause another liquidation cascade and push the price significantly further to the downside.

The BTC Pair The XRP/BTC pair mirrors this cautious tone of its USDT counterpart. XRP is hovering around 2,000 sats, holding near the recent lows and the key support area. The resistance clusters formed from the convergence of the 100-day and 200-day moving averages from 2,100 to 2,200 sats remain the primary obstacle for the buyers to push through in order to create a bullish outlook.

On the other hand, a breakdown of the support level at 2,000 sats could be disastrous, as it would likely lead to a deeper drop toward the lower boundary of the descending channel around 1,600 sats, or even below it toward the 1,500 sat horizontal support area. The repercussions of this scenario would be catastrophic, as it would create a very negative sentiment that would potentially take a long time to reverse.

Tags:

Although XRP has been showing mixed price action recently, with its price retracing back to levels seen before its latest rally, its exchange activity suggests that traders are still buying.

Latest exchange data provided by crypto analytics platform CryptoQuant shows that XRP is still in demand as the amount of tokens available on exchanges has declined substantially.

XRP supply shrinksPer the data, the amount of XRP sitting on all exchanges where it is listed, including Binance, has dropped to 2,750,702,461 XRP as of Saturday, March 28.

HOT Stories

This marks a significant decline from over 2.8 billion XRP recorded during the week, suggesting that XRP may be headed for a major price recovery this weekend.

It is important to note that the decline in the XRP exchange reserve is bullish for its potential price move as it reflects holders increasingly transferring XRP into private wallets, usually to hold. This is a key signal for increased buying activity, which could propel the price of XRP for higher surges.

You Might Also Like

Following the plummeting exchange reserve, XRP has suddenly flipped positive in its price after showing notable price declines in the previous day.

With a mild increase of 0.23%, XRP is back to trading in the green zone at $1.33 as of writing time. While sentiment had just flipped positive, this mild price increase could be the beginning of a major price breakout if the XRP buying activity continues to intensify.

XRP institutional holders still dormantWhile XRP has seen better price performance so far in March, with repeated price rallies pushing its price to break key resistance zones, institutional demand has stalled for the most part of the month.

As seen in the daily XRP ETF flows, the funds have continued to record little to no new institutional capital, with consistent withdrawals from investors.

While they have recorded the lowest performance this month, the XRP ETFs are on the verge of recording their first monthly outflow since launch.

Rebeca Moen Mar 28, 2026 15:10

ARB trades at $0.091 with RSI at 37.85 showing oversold conditions. Technical analysis suggests potential recovery to $0.11 upper Bollinger Band if current support holds.

ARB Price Prediction Summary • Short-term target (1 week): $0.095 • Medium-term forecast (1 month): $0.085-$0.11 range
• Bullish breakout level: $0.11 • Critical support: $0.089

What Crypto Analysts Are Saying About Arbitrum While specific analyst predictions are limited in recent crypto Twitter discussions, on-chain metrics suggest Arbitrum remains in a consolidation phase. According to current market data, ARB has maintained relative stability with minimal volatility, trading within a tight range that indicates accumulation patterns typical of Layer 2 tokens during market uncertainty.

The lack of recent KOL commentary on Arbitrum may actually be positive, as it suggests the token is avoiding negative sentiment that has plagued other altcoins. Market data platforms show consistent trading volumes around $3.27 million on Binance, indicating sustained institutional and retail interest despite the sideways price action.

ARB Technical Analysis Breakdown The current ARB price prediction hinges on several key technical indicators painting a mixed but cautiously optimistic picture. At $0.091, Arbitrum sits precariously close to its lower Bollinger Band support at $0.089, with the RSI reading of 37.85 suggesting oversold conditions without reaching extreme territory.

The MACD histogram at 0.0000 indicates bearish momentum has stalled, potentially signaling an upcoming reversal. With the Stochastic %K at 10.92 and %D at 8.73, ARB appears oversold on multiple timeframes, creating conditions favorable for a technical bounce.

Most telling is ARB's position relative to its moving averages. Trading significantly below the SMA 200 at $0.23 confirms the long-term bearish trend remains intact, but proximity to shorter-term averages (SMA 7 and 20 at $0.09-$0.10) suggests immediate support levels are being tested.

The Bollinger Band squeeze, with ARB's %B position at 0.1015, indicates the token is hugging the lower band – historically a zone where reversals occur when combined with oversold RSI conditions.

Arbitrum Price Targets: Bull vs Bear Case Bullish Scenario The Arbitrum forecast turns positive if ARB can reclaim the $0.092 level and hold above the lower Bollinger Band. A successful bounce from current levels targets the middle Bollinger Band at $0.10, representing a 9.5% upside move.

Breaking above $0.10 would likely trigger momentum toward the upper Bollinger Band at $0.11, offering a compelling 20% gain from current levels. This bullish ARB price prediction requires RSI to break above 50 and MACD to turn positive, confirming renewed buying pressure.

The key catalyst for upside would be broader Layer 2 narrative strength or specific Arbitrum ecosystem developments that drive renewed interest in ARB tokens.

Bearish Scenario Failure to hold current support at $0.089 could trigger a deeper correction toward psychological support at $0.08. The bearish case is supported by ARB trading 60% below its 200-day moving average, indicating the long-term trend remains firmly bearish.

A break below $0.085 would likely accelerate selling toward $0.07-$0.075, where previous consolidation zones might provide support. This scenario becomes probable if Bitcoin weakness continues or if Arbitrum faces specific technical or competitive challenges.

Should You Buy ARB? Entry Strategy Current oversold conditions present a tactical buying opportunity for risk-tolerant traders. The optimal entry strategy involves scaling into positions between $0.089-$0.091, with initial stops below $0.085 to limit downside risk.

Conservative investors should wait for confirmation above $0.095 before initiating positions, as this would signal the oversold bounce has begun. Dollar-cost averaging approaches work well given ARB's current range-bound behavior.

Position sizing should remain modest given the broader crypto market uncertainty and ARB's significant distance from long-term moving averages.

Conclusion This ARB price prediction suggests a near-term bounce to $0.095-$0.11 is probable based on oversold technical conditions, though longer-term challenges persist. The Arbitrum forecast remains cautiously optimistic for the next 1-4 weeks, with confidence level at 65% for the upside scenario.

Traders should monitor the $0.089 support level closely, as a decisive break would invalidate the bullish thesis. As with all cryptocurrency price predictions, this analysis is speculative and investors should conduct their own research before making trading decisions.

Disclaimer: Cryptocurrency investments carry significant risk. This analysis is for informational purposes only and should not be considered financial advice.

Image source: Shutterstock

arb price analysis arb price prediction

The Solana price is sending mixed signals because on one hand, the network is flexing serious dominance. On the other, the token itself? Not so much. It’s one of those classic crypto moments where fundamentals scream bullish, but price action quietly disagrees.

Let’s start with the headline stat. Solana has officially overtaken Ethereum in all-time unique developers. We’re talking 10,864 developers on Solana versus 9,017 on Ethereum, with Polkadot trailing at 8,995. That’s not a small gap in fact it’s a statement. The developer war, at least for now, has a new leader.

Solana Developer Growth Outpaces Ethereum And Polkadot SignificantlyDeveloper activity is often the backbone of long-term ecosystem growth. More builders usually mean more apps, more usage, and eventually, more value.

Add to that Solana’s claim of being one of the fastest networks, and surprisingly, the data backs it up. The chain is consistently maintaining over 3,000 transactions per second. That’s not theoretical throughput but it’s sustained activity.

Solana Price Weakens Despite Strong Network Fundamentals GrowthDespite all this progress, the Solana price has been under pressure. And no, it’s not some hidden flaw in the tech. The likely culprit is broader market weakness, combined with geopolitical uncertainty that tends to spook risk assets across the board.

Then there’s the technical side of things. Solana’s rally above $250 earlier created what now looks like a textbook supply zone. Price has been rejected from that level not once, not twice, but three times. That’s not random that’s sellers defending territory.

Volume peaked during that move, and since then? It’s been cooling off hard.

Futures Volume Bubble Map Shows Cooling Demand PressureSo, what’s actually happening under the hood? The futures volume bubble map paints a pretty clear picture. Demand isn’t just slowing but it’s fading. The aggressive buying that once pushed price higher has stepped back, leaving behind a market that’s trying to find balance.

And right now, that balance looks lower. The cooldown phase is still in progress, and if this trend continues, the Solana price could extend its decline toward the $52–$58 range. That’s where a more meaningful bottom might form only if buyers decide to show up again.

Until then, it’s a bit of a paradox. A network leading in developers, maintaining high throughput, and expanding its ecosystem… while its token struggles to keep up.

That’s crypto for you. Fundamentals build the story but price writes the headline. And right now, the Solana price headline isn’t exactly bullish.

Trust with CoinPedia:CoinPedia has been delivering accurate and timely cryptocurrency and blockchain updates since 2017. All content is created by our expert panel of analysts and journalists, following strict Editorial Guidelines based on E-E-A-T (Experience, Expertise, Authoritativeness, Trustworthiness). Every article is fact-checked against reputable sources to ensure accuracy, transparency, and reliability. Our review policy guarantees unbiased evaluations when recommending exchanges, platforms, or tools. We strive to provide timely updates about everything crypto & blockchain, right from startups to industry majors.

Investment Disclaimer:All opinions and insights shared represent the author's own views on current market conditions. Please do your own research before making investment decisions. Neither the writer nor the publication assumes responsibility for your financial choices.

Sponsored and Advertisements:Sponsored content and affiliate links may appear on our site. Advertisements are marked clearly, and our editorial content remains entirely independent from our ad partners.

Terrill Dicki Mar 28, 2026 15:28

WLD Price Prediction Summary • Short-term target (1 week): $0.29 • Medium-term forecast (1 month): $0.25-$0.32 range • Bullish breakout level: $0.30 • Critical support: $0.23 What Crypto Anal...

WLD Price Prediction Summary • Short-term target (1 week): $0.29 • Medium-term forecast (1 month): $0.25-$0.32 range
• Bullish breakout level: $0.30 • Critical support: $0.23

What Crypto Analysts Are Saying About Worldcoin While specific analyst predictions are limited for the current timeframe, historical analysis from early 2026 provides context. Joerg Hiller noted in January that "Worldcoin shows bullish momentum with MACD turning positive," targeting the $0.58-$0.62 range based on technical patterns. However, WLD has since retreated significantly from those levels.

According to on-chain data, Worldcoin's current trading patterns suggest a consolidation phase rather than the explosive growth predicted earlier this year. The token's substantial decline from the January highs indicates that previous bullish forecasts may have been overly optimistic given market conditions.

WLD Technical Analysis Breakdown Worldcoin's technical indicators present a mixed but cautiously neutral picture. The RSI at 34.12 sits in neutral territory, avoiding oversold conditions while suggesting limited momentum in either direction. This positioning typically indicates potential for a technical bounce rather than continued selling pressure.

The MACD histogram at -0.0000 shows bearish momentum has stalled, with the indicator potentially approaching a neutral crossover. While not yet bullish, this suggests the recent downtrend may be losing steam.

Bollinger Bands analysis reveals WLD trading at just 0.07 on the %B indicator, placing it extremely close to the lower band at $0.26. This proximity to the lower band often signals oversold conditions and potential support, particularly when combined with the current RSI reading.

Moving averages paint a bearish longer-term picture, with WLD trading below all major EMAs and SMAs. The SMA 7 at $0.30 represents immediate resistance, while the SMA 200 at $0.69 shows how far the token has declined from its longer-term trend.

Worldcoin Price Targets: Bull vs Bear Case Bullish Scenario A bullish WLD price prediction sees the token reclaiming the $0.30 resistance level, representing an 11% upside from current levels. Technical confirmation would require RSI breaking above 40 and MACD turning positive.

The next significant resistance sits at $0.34 (SMA 20), offering a potential 26% gain if momentum builds. For this Worldcoin forecast to materialize, trading volume would need to increase substantially from the current $37.5 million daily volume.

Bearish Scenario The bear case targets the strong support at $0.23, representing a 15% decline from current levels. A break below the Bollinger Band lower support at $0.26 could accelerate selling pressure toward this level.

Risk factors include continued weakness in the broader crypto market, declining trading volume, and the substantial gap between current prices and the SMA 200 at $0.69, indicating long-term bearish sentiment remains intact.

Should You Buy WLD? Entry Strategy For traders considering WLD, the current level near $0.27 offers a reasonable risk-reward setup. Entry points around $0.26-$0.27 provide proximity to technical support while targeting the $0.30 resistance for a measured move higher.

A disciplined approach would place stop-loss orders below $0.24 to limit downside risk. This represents the daily low and a logical invalidation level for any bullish thesis.

Risk management remains crucial given Worldcoin's high volatility, with the ATR at $0.03 indicating significant daily price swings. Position sizing should account for this volatility when establishing any WLD positions.

Conclusion The WLD price prediction suggests a cautious recovery toward $0.30 over the coming weeks, supported by neutral RSI conditions and proximity to Bollinger Band support. However, the broader technical picture remains challenged by bearish moving averages and substantial distance from longer-term trends.

This Worldcoin forecast carries moderate confidence given the mixed technical signals. While oversold conditions suggest potential for a bounce, sustained recovery would require significant volume and momentum shifts that aren't yet evident in current market data.

Cryptocurrency price predictions are inherently speculative and subject to extreme volatility. This analysis is for informational purposes only and should not be considered investment advice. Always conduct your own research and consider your risk tolerance before making investment decisions.

Image source: Shutterstock

wld price analysis wld price prediction

Ripple (XRP) continues to slide after a steep year-to-date drawdown, even as the company pushes deeper into ‘institutional-grade’ market infrastructure and the U.S. spot ETF market for XRP expands—developments that many analysts see as potential medium-term catalysts once demand catches up to the plumbing.

As of Friday U.S. Eastern Time, XRP was changing hands around $1.34, down more than 40% since the start of 2026 and hovering near the lower end of a multi-month range. The token’s slump has left it among the weakest performers in the top tier of digital assets this year, underscoring the gap between improving market access and immediate price support.

Ripple President Monica Long has framed 2026 as the first true year of ‘institutional adoption’ for the network, pointing to Ripple’s $1.25 billion acquisition of Hidden Road as a pivotal step. According to Ripple, the deal strengthens its connectivity to traditional market rails, including access linked to post-trade infrastructure such as the Depository Trust & Clearing Corporation (DTCC) and the National Securities Clearing Corporation (NSCC)—pipes that matter for prime brokerage-style workflows, collateral movement, and large-scale trading operations.

At the same time, the investable wrapper around XRP has grown. Six spot XRP ETFs are currently in operation with combined assets reportedly above $1 billion, a milestone that proponents argue can broaden the buyer base beyond crypto-native venues. Regulatory uncertainty has also eased since U.S. regulators—cited as the Securities and Exchange Commission and the Commodity Futures Trading Commission—officially categorized XRP as a ‘commodity’ on March 17, reducing one of the key overhangs that had discouraged some institutions.

Still, the market has yet to reward the narrative. XRP has remained trapped in a roughly $1.32–$1.42 band, far below earlier 2026 highs reported around $2.40–$3.65. Market participants point to several headwinds: an elevated correlation with Bitcoin (BTC) near 0.80, persistent profit-taking by large holders following the peak, and resistance from underwater supply. Estimates cited in the market suggest roughly 60% of XRP supply sits at a loss, creating a heavy sell zone as price approaches the $1.44–$1.76 region.

Quarterly rebalancing has added additional pressure as institutional portfolios cut exposure to laggards. “In a risk-off tape, assets that underperform become the first source of liquidity,” one derivatives trader said, describing the mechanical nature of rebalancing flows rather than a rejection of XRP’s longer-term thesis.

From a technical perspective, traders are watching the 200-day moving average near $1.38 as a near-term pivot. Resistance is commonly cited in the $1.45–$1.50 range, with volatility measures compressed to some of the lowest levels seen this year—often a setup that precedes larger directional moves, though the timing and direction remain uncertain.

Derivatives positioning, however, has turned more constructive into the latest ETF-related timeline. With the final window for an SEC decision on additional spot ETF approvals falling around March 27–28, open interest and funding rates have been rising, signaling a build in leveraged long exposure. Market data cited in the report indicated seven XRP-related funding products are currently active, with approximately $1.4 billion in inflows, while Grayscale is preparing to convert an existing trust structure into an ETF format.

Ripple’s broader payments network also continues to expand. RippleNet, the company’s cross-border settlement network, maintains partnerships with more than 300 banks, though no new detailed roadmap was confirmed in the latest update. Instead, Ripple has emphasized that the Hidden Road acquisition is designed to deepen links between crypto liquidity and traditional finance workflows—an area where institutional adoption is often gated by compliance, clearing, and operational requirements as much as by market conviction.

Price targets around XRP remain widely dispersed. Standard Chartered reportedly cut its 2026 target for XRP to $2.80 from $8, while keeping a long-dated view that XRP could reach $28 by 2030. FXEmpire, by contrast, has floated a shorter-term objective near $5. Such projections face a structural variable unique to XRP’s supply dynamics: up to 1 billion XRP can be released monthly from escrow, a mechanism that can add to effective sell pressure depending on how much is distributed and absorbed by the market.

On the day, XRP was down about 1.8% over 24 hours, with trading volume around $2.2 billion—lower than the prior session—while its market capitalization stood near $81.9 billion, holding its position around fifth among cryptocurrencies. For now, investors appear to be waiting for clearer evidence that expanded ‘ETF access’ and upgraded ‘institutional rails’ translate into sustained net inflows, rather than simply improving the ability to trade an asset that remains closely tethered to broader crypto risk sentiment.

<Copyright ⓒ TokenPost, unauthorized reproduction and redistribution prohibited>

Bitcoin (BTC) price has dropped roughly 9% since briefly touching $72,000 on March 25, erasing all 30-day gains and entering negative territory at -2.6% over the month. It is currently trading flat over the past 24 hours near $66,900.

The decline produced a bearish breakdown of a pattern on the 12-hour chart. However, a hidden bullish divergence suggests a short-term bounce is possible. Whether that bounce has enough fuel to clear the overhead supply depends on the on-chain data.

Head and Shoulders Breaks Down on the 12-Hour ChartThe 12-hour BTC price chart shows a head and shoulders pattern that has been developing since late February. The neckline sat near $67,700, and the breakdown happened on March 27.

BTC Head and Shoulders Breakdown: TradingViewWant more token insights like this? Sign up for Editor Harsh Notariya’s Daily Crypto Newsletter here.

On paper, the pattern’s measured move points to a 12% correction from the neckline. If realized, that would push Bitcoin price below the $60,000 psychological mark, targeting the $59,400 zone.

However, the Relative Strength Index (RSI), a momentum oscillator, offers a counter-reading. Between February 28 and March 27, the price formed a higher low while the RSI formed a lower low.

That hidden bullish divergence, which typically hints at trend continuation rather than reversal, has already produced a 1.87% bounce from the recent low.

RSI Hidden Bullish Divergence: TradingViewThe divergence suggests the floor near $65,000 may hold temporarily. However, the bounce faces a wall of supply directly overhead, and the whales who would normally push through it are not providing enough conviction.

Over 6% of Supply Sits Between $66,900 and $69,400The UTXO Realized Price Distribution (URPD), a Glassnode metric that maps the price at which Bitcoin’s current supply was last transacted, reveals three dense clusters directly above the current price.

At $66,900 (close to the current price), roughly 2.37% of the total supply last changed hands. At $68,100, another 1.96% sits. And at $69,400, a further 1.96%. Combined, approximately 6.29% of the BTC supply is concentrated in a $2,500 range just above where Bitcoin trades now.

BTC UTXO Realized Price Distribution: GlassnodeThese clusters act as resistance because holders who bought at those prices and are currently sitting near breakeven tend to sell into any bounce to exit at minimal loss.

Whale behavior confirms how alarming these Bitcoin supply zones are currently. The largest cohort holding between 100,000 and 1 million BTC reduced their stash from 675,200 to 670,000 on March 24, a 5,200 BTC drop.

The mid-tier cohort (10,000 to 100,000) dipped and recovered, ending roughly flat at 2.25 million. Only the smallest whale tier (1,000 to 10,000) added marginally, rising from 4.21 million to 4.22 million.

BTC Whale Cohort Balances: SantimentThe net effect across all three cohorts is a marginal addition of roughly 4,800 BTC. However, the conviction picture is weaker than that number suggests.

The biggest wallets, which carry the most market-moving weight, reduced exposure by 5,200 BTC. The smallest tier’s 10,000 BTC addition does not offset that in terms of directional influence, because large-holder distribution historically precedes further weakness, while smaller-tier accumulation often reflects dip-buying that gets absorbed by overhead supply.

That means any bounce from the hidden bullish divergence is likely to stall within the $66,900 to $69,400 range (the supply warning we highlighted earlier).

Bitcoin Price Forecast and the $66,600 LineThe most immediate deciding level for Bitcoin is $66,600. Holding above it means the immediate supply cluster has not yet triggered mass selling, yet. A bounce from here could push toward $68,700 and the $70,000 psychological level.

However, $70,000 would require clearing all three supply clusters. Given the weak whale conviction, any bounce under $70,000 remains at risk of another sell wave. The bearish structure only weakens above $72,000, the right shoulder high.

On the downside, losing $66,600 opens the path to $65,200 and $63,300. Below that, the head-and-shoulders measured move of roughly 12% targets the $59,400 zone, pushing Bitcoin below $60,000 for the first time since the February lows.

Bitcoin Price Analysis: TradingViewFor now, $66,600 separates a shallow bounce toward $69,400 from a measured move breakdown below $60,000.

Rongchai Wang Mar 28, 2026 15:46

FLOKI trades sideways at $0.00002855 with neutral RSI at 45.30. Technical analysis points to potential $0.000035 breakout target within 4 weeks as meme coin sector stabilizes.

FLOKI Price Prediction Summary • Short-term target (1 week): $0.000030 • Medium-term forecast (1 month): $0.000025-$0.000035 range
• Bullish breakout level: $0.000035 • Critical support: $0.000025

What Crypto Analysts Are Saying About Floki While specific analyst predictions are limited for FLOKI in recent weeks, on-chain data from platforms like CryptoQuant and Glassnode suggests meme coin sectors are experiencing consolidation phases. According to recent market analysis, smaller altcoins including FLOKI have shown resilience during Bitcoin's volatility periods.

The F5 Crypto Fund's January 2026 report highlighted that exposure to smaller coins like FLOKI helped mitigate portfolio losses during market downturns, indicating institutional interest in diversified crypto strategies beyond major assets. This suggests FLOKI's utility extends beyond pure speculation, though the token remains highly correlated with broader meme coin sentiment.

FLOKI Technical Analysis Breakdown FLOKI's current technical setup presents a mixed but stabilizing picture. The RSI reading of 45.30 indicates neutral momentum, neither overbought nor oversold, suggesting the token is in a consolidation phase rather than trending strongly in either direction.

The MACD histogram shows bearish momentum at effectively zero, indicating minimal selling pressure but also lack of bullish catalyst. This flat MACD structure often precedes significant moves as the market decides direction.

Bollinger Band positioning at 0.2521 places FLOKI closer to the lower band, suggesting the price has room to move higher within the current volatility range. The 24-hour trading volume of $1,495,138 on Binance indicates moderate interest, though not exceptional for a meme coin of FLOKI's market cap.

The Stochastic indicators (%K at 20.14, %D at 16.11) suggest FLOKI is approaching oversold territory, which could provide buying opportunities for traders looking for mean reversion plays.

Floki Price Targets: Bull vs Bear Case Bullish Scenario In a bullish breakout scenario, FLOKI price prediction points toward the $0.000035 level as the primary target. This represents approximately 23% upside from current levels and aligns with previous resistance zones that could act as magnets during positive momentum.

Technical confirmation would require RSI breaking above 55 and MACD histogram turning decisively positive. A break above the middle Bollinger Band with increased volume would signal the start of a sustained upward move.

Bearish Scenario The bearish case for this Floki forecast targets the $0.000025 support level, representing roughly 12% downside risk. This level has historically provided strong support and coincides with longer-term moving average confluence.

Risk factors include broader crypto market weakness, regulatory concerns affecting meme coins, or decreased retail interest in speculative assets. A breakdown below $0.000025 could trigger further selling toward $0.000020.

Should You Buy FLOKI? Entry Strategy For traders considering FLOKI positions, the current price around $0.00002855 offers a reasonable risk-reward setup. Conservative entry would involve dollar-cost averaging between $0.000027-$0.000029, allowing for some downside buffer.

Stop-loss placement below $0.000025 would limit downside to approximately 12%, while upside targets of $0.000032-$0.000035 provide favorable 2:1 risk-reward ratios. Position sizing should remain conservative given FLOKI's volatility characteristics.

Risk management is crucial with meme coins. Never allocate more than 2-3% of portfolio to speculative assets like FLOKI, and consider taking profits incrementally as targets are reached rather than holding for maximum gains.

Conclusion This FLOKI price prediction suggests a neutral-to-slightly-bullish outlook over the next 4 weeks. The technical setup indicates consolidation near current levels with potential for a move toward $0.000035 if broader crypto sentiment improves.

The balanced risk-reward profile makes FLOKI suitable for traders comfortable with meme coin volatility, though conservative position sizing remains essential. Monitor RSI and MACD for confirmation of directional bias before increasing exposure.

Disclaimer: Cryptocurrency price predictions are speculative and involve significant risk. Never invest more than you can afford to lose, and always conduct your own research before making investment decisions.

Image source: Shutterstock

floki price analysis floki price prediction